Matrix Metalloproteinase-2 and -9 Levels in Obese Patients

G. Derosa, I. Ferrari, A. D'Angelo, C. Tinelli, S. A T Salvadeo, L. Ciccarelli, M. N. Piccinni, A. Gravina, F. Ramondetti, P. Maffioli, A. F G Cicero

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

The data reported in literature revealed a novel function for matrix metalloproteinases (MMPs) as modulators of adipogenesis. However, their expression profile and role in the cellular microenvironment during obesity-mediated adipose tissue development remain poorly defined. The authors hypothesized that MMP-2 and MMP-9 levels might be abnormal in obesity, reflecting alterations in extracellular matrix (ECM) turnover. One hundred and sixty three obese patients and 165 controls were enrolled. The following were measured: body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), fasting plasma insulin (FPI), homeostasis model assessment (HOMA) index, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (Tg), lipoprotein(a) (Lp(a)), and plasma levels of MMP-2 and MMP-9. A significant increase of BMI and WC (p <.0001) was observed in obese patients. No FPG change was present in obese group, whereas FPI and HOMA index increases (p <.0001) were obtained in obese patients compared to control subjects. No SBP and DBP variations were observed in obese group. Significant TC and LDL-C increases (p <.0001) were present in obese patients, whereas no HDL-C, Tg, and Lp(a) changes were obtained in both groups. MMP-2 and MMP-9 levels were significantly higher in obese group (p <.0001). Plasma levels of MMP-2 and MMP-9 are increased in obese patients which may reflect abnormal ECM metabolism.

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalEndothelium: Journal of Endothelial Cell Research
Volume15
Issue number4
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Blood Pressure
Fasting
Lipoprotein(a)
Waist Circumference
LDL Cholesterol
HDL Cholesterol
Extracellular Matrix
Triglycerides
Body Mass Index
Homeostasis
Obesity
Cholesterol
Insulin
Cellular Microenvironment
Glucose
Adipogenesis
Matrix Metalloproteinases
Adipose Tissue

Keywords

  • Extracellular Matrix
  • Metalloproteinases
  • Obesity

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

Matrix Metalloproteinase-2 and -9 Levels in Obese Patients. / Derosa, G.; Ferrari, I.; D'Angelo, A.; Tinelli, C.; Salvadeo, S. A T; Ciccarelli, L.; Piccinni, M. N.; Gravina, A.; Ramondetti, F.; Maffioli, P.; Cicero, A. F G.

In: Endothelium: Journal of Endothelial Cell Research, Vol. 15, No. 4, 07.2008, p. 219-224.

Research output: Contribution to journalArticle

Derosa, G. ; Ferrari, I. ; D'Angelo, A. ; Tinelli, C. ; Salvadeo, S. A T ; Ciccarelli, L. ; Piccinni, M. N. ; Gravina, A. ; Ramondetti, F. ; Maffioli, P. ; Cicero, A. F G. / Matrix Metalloproteinase-2 and -9 Levels in Obese Patients. In: Endothelium: Journal of Endothelial Cell Research. 2008 ; Vol. 15, No. 4. pp. 219-224.
@article{4579d65b058e47b8a88f2adbba247f3d,
title = "Matrix Metalloproteinase-2 and -9 Levels in Obese Patients",
abstract = "The data reported in literature revealed a novel function for matrix metalloproteinases (MMPs) as modulators of adipogenesis. However, their expression profile and role in the cellular microenvironment during obesity-mediated adipose tissue development remain poorly defined. The authors hypothesized that MMP-2 and MMP-9 levels might be abnormal in obesity, reflecting alterations in extracellular matrix (ECM) turnover. One hundred and sixty three obese patients and 165 controls were enrolled. The following were measured: body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), fasting plasma insulin (FPI), homeostasis model assessment (HOMA) index, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (Tg), lipoprotein(a) (Lp(a)), and plasma levels of MMP-2 and MMP-9. A significant increase of BMI and WC (p <.0001) was observed in obese patients. No FPG change was present in obese group, whereas FPI and HOMA index increases (p <.0001) were obtained in obese patients compared to control subjects. No SBP and DBP variations were observed in obese group. Significant TC and LDL-C increases (p <.0001) were present in obese patients, whereas no HDL-C, Tg, and Lp(a) changes were obtained in both groups. MMP-2 and MMP-9 levels were significantly higher in obese group (p <.0001). Plasma levels of MMP-2 and MMP-9 are increased in obese patients which may reflect abnormal ECM metabolism.",
keywords = "Extracellular Matrix, Metalloproteinases, Obesity",
author = "G. Derosa and I. Ferrari and A. D'Angelo and C. Tinelli and Salvadeo, {S. A T} and L. Ciccarelli and Piccinni, {M. N.} and A. Gravina and F. Ramondetti and P. Maffioli and Cicero, {A. F G}",
year = "2008",
month = "7",
doi = "10.1080/10623320802228815",
language = "English",
volume = "15",
pages = "219--224",
journal = "Endothelium: Journal of Endothelial Cell Research",
issn = "1062-3329",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Matrix Metalloproteinase-2 and -9 Levels in Obese Patients

AU - Derosa, G.

AU - Ferrari, I.

AU - D'Angelo, A.

AU - Tinelli, C.

AU - Salvadeo, S. A T

AU - Ciccarelli, L.

AU - Piccinni, M. N.

AU - Gravina, A.

AU - Ramondetti, F.

AU - Maffioli, P.

AU - Cicero, A. F G

PY - 2008/7

Y1 - 2008/7

N2 - The data reported in literature revealed a novel function for matrix metalloproteinases (MMPs) as modulators of adipogenesis. However, their expression profile and role in the cellular microenvironment during obesity-mediated adipose tissue development remain poorly defined. The authors hypothesized that MMP-2 and MMP-9 levels might be abnormal in obesity, reflecting alterations in extracellular matrix (ECM) turnover. One hundred and sixty three obese patients and 165 controls were enrolled. The following were measured: body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), fasting plasma insulin (FPI), homeostasis model assessment (HOMA) index, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (Tg), lipoprotein(a) (Lp(a)), and plasma levels of MMP-2 and MMP-9. A significant increase of BMI and WC (p <.0001) was observed in obese patients. No FPG change was present in obese group, whereas FPI and HOMA index increases (p <.0001) were obtained in obese patients compared to control subjects. No SBP and DBP variations were observed in obese group. Significant TC and LDL-C increases (p <.0001) were present in obese patients, whereas no HDL-C, Tg, and Lp(a) changes were obtained in both groups. MMP-2 and MMP-9 levels were significantly higher in obese group (p <.0001). Plasma levels of MMP-2 and MMP-9 are increased in obese patients which may reflect abnormal ECM metabolism.

AB - The data reported in literature revealed a novel function for matrix metalloproteinases (MMPs) as modulators of adipogenesis. However, their expression profile and role in the cellular microenvironment during obesity-mediated adipose tissue development remain poorly defined. The authors hypothesized that MMP-2 and MMP-9 levels might be abnormal in obesity, reflecting alterations in extracellular matrix (ECM) turnover. One hundred and sixty three obese patients and 165 controls were enrolled. The following were measured: body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), fasting plasma insulin (FPI), homeostasis model assessment (HOMA) index, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (Tg), lipoprotein(a) (Lp(a)), and plasma levels of MMP-2 and MMP-9. A significant increase of BMI and WC (p <.0001) was observed in obese patients. No FPG change was present in obese group, whereas FPI and HOMA index increases (p <.0001) were obtained in obese patients compared to control subjects. No SBP and DBP variations were observed in obese group. Significant TC and LDL-C increases (p <.0001) were present in obese patients, whereas no HDL-C, Tg, and Lp(a) changes were obtained in both groups. MMP-2 and MMP-9 levels were significantly higher in obese group (p <.0001). Plasma levels of MMP-2 and MMP-9 are increased in obese patients which may reflect abnormal ECM metabolism.

KW - Extracellular Matrix

KW - Metalloproteinases

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=48549083755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48549083755&partnerID=8YFLogxK

U2 - 10.1080/10623320802228815

DO - 10.1080/10623320802228815

M3 - Article

VL - 15

SP - 219

EP - 224

JO - Endothelium: Journal of Endothelial Cell Research

JF - Endothelium: Journal of Endothelial Cell Research

SN - 1062-3329

IS - 4

ER -